Press Releases

2026 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008

May 28, 2026

Ironwood Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference

May 27, 2026

FDA Approves Use of LINZESS® (linaclotide) in Pediatric Patients Two Years of Age and Older with Functional Constipation (FC)

May 7, 2026

Ironwood Pharmaceuticals Reports Strong First Quarter 2026 Results With 97% Year-Over-Year LINZESS U.S. Net Sales Growth; Maintains Full-Year 2026 Financial Guidance

May 4, 2026

Ironwood Survey Findings at DDW 2026 Underscore Need for Therapies that Address Multiple Dimensions of Total Parenteral Nutrition (TPN) Burden in Short Bowel Syndrome (SBS)

April 30, 2026

Ironwood Pharmaceuticals to Host First Quarter 2026 Investor Update Call

April 23, 2026

Ironwood Pharmaceuticals to Share Real-World HCP Perspectives on Burden of Total Parenteral Nutrition in Short Bowel Syndrome (SBS) at Digestive Disease Week® 2026

March 4, 2026

Ironwood Pharmaceuticals to Participate in The Citizens Life Sciences Conference

February 25, 2026

Ironwood Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Results; Achieves 2025 Financial Guidance and Reiterates Strong 2026 Outlook

February 18, 2026

Ironwood Pharmaceuticals to Host Fourth Quarter and Full Year 2025 Investor Update Call

January 2, 2026

Ironwood Pharmaceuticals Maintains FY 2025 Financial Guidance and Announces FY 2026 Financial Guidance